Prof Rob Ramsay
Honorary (Professorial Fellow)
The Sir Peter MacCallum Department of Oncology
248 Scholarly works
16 Projects
HIGHLIGHTS
2025
Journal article
Role of Neoadjuvant Immune Checkpoint Inhibitors in Locally Advanced Rectal Cancer: A Systematic Review of Currently Available Studies
DOI: 10.1097/DCR.00000000000039272025
Journal article
The Ave–Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal Cancer
DOI: 10.1158/1078-0432.CCR-25-07052025
Journal article
Discovery of WEE1 Kinase Inhibitors with Potent Activity against Patient-Derived, Metastatic Colorectal Cancer Organoids
DOI: 10.1021/acs.jmedchem.4c025412025
Journal article
A non-randomised open-label exploratory ‘window of opportunity’ study of TG02 treatment in patients with locally advanced primary and recurrent RAS mutant colorectal cancer
DOI: 10.1016/j.heliyon.2024.e413642019
Research Grant
From the Stone Age to the State of the Art – Multidimensional Precision Medicine for Peritoneal CRC
2018
Research Grant
Testing a New Anti-Cancer Vaccine as a Therapy for Brain Cancer
2018
Research Grant
Mechanisms of Resistance to Immunological Targeting of Primary and Metastatic Colorectal Cancers
RECENT SCHOLARLY WORKS
2024
Journal article
Targeting alternative classes of tumor antigens to improve immunotherapy for microsatellite stable, mismatch repair-proficient colorectal cancer
DOI: 10.1158/1538-7445.AM2024-40952024
Journal article
CREB: A multifaceted transcriptional regulator of neural and immune function in CNS tumors
DOI: 10.1016/j.bbi.2023.12.0022024
Journal article
Impact of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal adenocarcinoma
DOI: 10.1111/ajco.139492023
Journal article
Use of patient-derived explants as a preclinical model for precision medicine in colorectal cancer: A scoping review
DOI: 10.1007/s00423-023-03133-72023
Conference Proceedings
The ave-rec phase II trial of PD-L1/PD-1 blockade with avelumab plus chemoradiotherapy for resectable ESMO high risk rectal cancers
DOI: 10.1016/j.annonc.2023.09.18242023
Journal article
ASO Author Reflections: Humidification of Carbon Dioxide for Insufflation Offers Promise in Reducing Inflammation and Peritoneal Trauma During and Post Colorectal Cancer Surgery
DOI: 10.1245/s10434-022-13014-w
RECENT PROJECTS
2024
Research grants (other domestic)
"The PREDICTORG Trial: PeRsonalisED Intraperitoneal Chemotherapy for Patients With resecTable Colorectal Peritoneal Metastases: An All-Australian Multicentre Trial Utilising Patient-Derived Tumour ORGanoids to Facilitate Precision Medicine."
2020
Research grants (other domestic)
Novel Neo-Adjuvant Therapy for Locally Advanced Rectal Cancer